Gynostemma saponins (Actiponin)
Gynostemma pentaphyllum (Actiponin / Gypenosides) · also known as Jiaogulan extract, Gypenosides, Actiponin
A randomized trial of standardized Gynostemma extract (Actiponin) at 450 mg/day observed changes in abdominal fat measures. Evidence for AMPK activation comes mainly from animal and cell studies, and its effect in human tissue has not been measured directly.
Clinical uses and human evidence
Body weight and body fat
Blood sugar and insulin resistance
Fatigue and energy
Endurance performance
Mechanisms of action
AMPK sensing of cellular energy deficit and metabolic reprogramming
Gynostemma saponins are thought to promote phosphorylation of AMPK at Thr172 through an upstream kinase, which in turn inhibits acetyl-CoA carboxylase and reduces fat synthesis. Increased AMPK phosphorylation has been seen in animal liver, but whether this happens in human tissue has not been measured directly.
Endothelial nitric oxide synthase (eNOS) coupling and NO vasodilation
Gynostemma extract can increase nitric oxide release from cultured endothelial cells and can relax isolated blood vessels. One randomized trial measured higher blood eNOS levels, but there is no direct evidence that this means better coronary or microvascular dilation.
Safety and drug interactions
Low blood sugar risk
May lower blood sugar. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.